- Home
- FTHY vs NKTR Comparison
FTHY vs NKTR Comparison
Compare FTHY & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHY
- NKTR
- Stock Information
- Founded
- FTHY 2020
- NKTR 1990
- Country
- FTHY United States
- NKTR United States
- Employees
- FTHY N/A
- NKTR N/A
- Industry
- FTHY Investment Managers
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- FTHY Finance
- NKTR Health Care
- Exchange
- FTHY Nasdaq
- NKTR Nasdaq
- Market Cap
- FTHY 536.9M
- NKTR 558.0M
- IPO Year
- FTHY N/A
- NKTR 1994
- Fundamental
- Price
- FTHY $14.57
- NKTR $40.18
- Analyst Decision
- FTHY
- NKTR Strong Buy
- Analyst Count
- FTHY 0
- NKTR 6
- Target Price
- FTHY N/A
- NKTR $81.67
- AVG Volume (30 Days)
- FTHY 176.7K
- NKTR 884.5K
- Earning Date
- FTHY 01-01-0001
- NKTR 11-06-2025
- Dividend Yield
- FTHY 10.93%
- NKTR N/A
- EPS Growth
- FTHY N/A
- NKTR N/A
- EPS
- FTHY N/A
- NKTR N/A
- Revenue
- FTHY N/A
- NKTR $74,934,000.00
- Revenue This Year
- FTHY N/A
- NKTR N/A
- Revenue Next Year
- FTHY N/A
- NKTR N/A
- P/E Ratio
- FTHY N/A
- NKTR N/A
- Revenue Growth
- FTHY N/A
- NKTR N/A
- 52 Week Low
- FTHY $12.66
- NKTR $6.48
- 52 Week High
- FTHY $14.74
- NKTR $40.45
- Technical
- Relative Strength Index (RSI)
- FTHY 46.90
- NKTR 82.74
- Support Level
- FTHY $14.40
- NKTR $27.87
- Resistance Level
- FTHY $14.68
- NKTR $30.45
- Average True Range (ATR)
- FTHY 0.11
- NKTR 2.10
- MACD
- FTHY -0.01
- NKTR 0.96
- Stochastic Oscillator
- FTHY 51.67
- NKTR 98.21
About FTHY First Trust High Yield Opportunities 2027 Term Fund
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.